Literature DB >> 22874519

Identification of HIV-1-specific regulatory T-cells using HLA class II tetramers.

Mathieu Angin1, Melanie King, Marcus Altfeld, Bruce D Walker, Kai W Wucherpfennig, Marylyn M Addo.   

Abstract

Regulatory T cells (Tregs) are potent immune modulators, but their precise role in HIV pathogenesis remains incompletely understood. Most studies to date have focused on frequencies or phenotypes of 'bulk' Treg populations. However, although antigen-specific Tregs have been reported in other diseases, HIV-1 epitope-specific Tregs have not been described to date. We here report the first identification of functional HIV-1-Gag-specific regulatory T cells using human leukocyte antigen class II tetramer staining in HIV-1-infected individuals.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22874519      PMCID: PMC3825094          DOI: 10.1097/QAD.0b013e328358cc75

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  19 in total

1.  Cutting edge: CD4+CD25+ regulatory T cells contribute to gender differences in susceptibility to experimental autoimmune encephalomyelitis.

Authors:  Jay Reddy; Hanspeter Waldner; Xingmin Zhang; Zsolt Illes; Kai W Wucherpfennig; Raymond A Sobel; Vijay K Kuchroo
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

2.  Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease.

Authors:  Julian Schulze Zur Wiesch; Adriana Thomssen; Philip Hartjen; Ilona Tóth; Clara Lehmann; Dirk Meyer-Olson; Kristina Colberg; Sebastian Frerk; Dalia Babikir; Stefan Schmiedel; Olaf Degen; Stefan Mauss; Jürgen Rockstroh; Schlomo Staszewski; Pavel Khaykin; Alexander Strasak; Ansgar W Lohse; Gerd Fätkenheuer; Joachim Hauber; Jan van Lunzen
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

3.  Regulatory T cells control HIV replication in activated T cells through a cAMP-dependent mechanism.

Authors:  Maria E Moreno-Fernandez; Cesar Mauricio Rueda; Laura K Rusie; Claire A Chougnet
Journal:  Blood       Date:  2011-03-23       Impact factor: 22.113

4.  Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers.

Authors:  Julia M Shaw; Peter W Hunt; J William Critchfield; Delandy H McConnell; Juan Carlos Garcia; Richard B Pollard; Ma Somsouk; Steven G Deeks; Barbara L Shacklett
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

5.  Preserved function of regulatory T cells in chronic HIV-1 infection despite decreased numbers in blood and tissue.

Authors:  Mathieu Angin; Douglas S Kwon; Hendrik Streeck; Fang Wen; Melanie King; Ashley Rezai; Kenneth Law; Tomoyuki C Hongo; Augustine Pyo; Alicja Piechocka-Trocha; Ildiko Toth; Florencia Pereyra; Musie Ghebremichael; Scott J Rodig; Danny A Milner; James M Richter; Marcus Altfeld; Daniel E Kaufmann; Bruce D Walker; Marylyn M Addo
Journal:  J Infect Dis       Date:  2012-03-15       Impact factor: 5.226

6.  Identification of circulating human antigen-reactive CD4+ FOXP3+ natural regulatory T cells.

Authors:  Nicolle H R Litjens; Karin Boer; Michiel G H Betjes
Journal:  J Immunol       Date:  2011-12-21       Impact factor: 5.422

7.  Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis.

Authors:  Jayagopala Reddy; Zsolt Illes; Xingmin Zhang; Jeffrey Encinas; Jason Pyrdol; Lindsay Nicholson; Raymond A Sobel; Kai W Wucherpfennig; Vijay K Kuchroo
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-18       Impact factor: 11.205

8.  Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers.

Authors:  Cheryl L Day; Nilufer P Seth; Michaela Lucas; Heiner Appel; Laurent Gauthier; Georg M Lauer; Gregory K Robbins; Zbigniew M Szczepiorkowski; Deborah R Casson; Raymond T Chung; Shannon Bell; Gillian Harcourt; Bruce D Walker; Paul Klenerman; Kai W Wucherpfennig
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

9.  HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells.

Authors:  Andrew Prendergast; Julia G Prado; Yu-Hoi Kang; Fabian Chen; Lynn A Riddell; Graz Luzzi; Philip Goulder; Paul Klenerman
Journal:  AIDS       Date:  2010-02-20       Impact factor: 4.177

10.  Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor.

Authors:  Makoto Miyara; Yumiko Yoshioka; Akihiko Kitoh; Tomoko Shima; Kajsa Wing; Akira Niwa; Christophe Parizot; Cécile Taflin; Toshio Heike; Dominique Valeyre; Alexis Mathian; Tatsutoshi Nakahata; Tomoyuki Yamaguchi; Takashi Nomura; Masahiro Ono; Zahir Amoura; Guy Gorochov; Shimon Sakaguchi
Journal:  Immunity       Date:  2009-05-21       Impact factor: 31.745

View more
  11 in total

1.  Differential regulatory T cell activity in HIV type 1-exposed seronegative individuals.

Authors:  Laura Pattacini; Pamela M Murnane; Erin M Kahle; Michael J Bolton; Jeffrey J Delrow; Jairam R Lingappa; Elly Katabira; Deborah Donnell; M Juliana McElrath; Jared M Baeten; Jennifer M Lund
Journal:  AIDS Res Hum Retroviruses       Date:  2013-07-30       Impact factor: 2.205

2.  Phenotypic characterization of regulatory T cells from antiretroviral-naive HIV-1-infected people.

Authors:  Georgia N Ambada; Claudine E Ntsama; Nadesh N Nji; Loveline N Ngu; Carole N Sake; Abel Lissom; Flaurent T Tchouangeu; Jules Tchadji; Martin Sosso; François-Xavier Etoa; Godwin W Nchinda
Journal:  Immunology       Date:  2017-05-18       Impact factor: 7.397

3.  Decreased HIV-specific T-regulatory responses are associated with effective DC-vaccine induced immunity.

Authors:  Vedran Brezar; Nicolas Ruffin; Laura Richert; Mathieu Surenaud; Christine Lacabaratz; Karolina Palucka; Rodolphe Thiébaut; Jacques Banchereau; Yves Levy; Nabila Seddiki
Journal:  PLoS Pathog       Date:  2015-03-27       Impact factor: 6.823

4.  Generation and immunosuppressive functions of p53-induced human adaptive regulatory T cells.

Authors:  Magis Mandapathil; Carmen Visus; Olivera J Finn; Stephan Lang; Theresa L Whiteside
Journal:  Oncoimmunology       Date:  2013-07-03       Impact factor: 8.110

5.  Smarter vaccine design will circumvent regulatory T cell-mediated evasion in chronic HIV and HCV infection.

Authors:  Leonard Moise; Frances Terry; Andres H Gutierrez; Ryan Tassone; Phyllis Losikoff; Stephen H Gregory; Chris Bailey-Kellogg; William D Martin; Anne S De Groot
Journal:  Front Microbiol       Date:  2014-10-06       Impact factor: 5.640

6.  Nanotechnology as a New Therapeutic Approach to Prevent the HIV-Infection of Treg Cells.

Authors:  Didiana Jaramillo-Ruiz; Francisco Javier De La Mata; Rafael Gómez; Rafael Correa-Rocha; M Ángeles Muñoz-Fernández
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

Review 7.  T-Regulatory Cells and Vaccination "Pay Attention and Do Not Neglect Them": Lessons from HIV and Cancer Vaccine Trials.

Authors:  Vedran Brezar; Véronique Godot; Liang Cheng; Lishan Su; Yves Lévy; Nabila Seddiki
Journal:  Vaccines (Basel)       Date:  2016-09-05

Review 8.  Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies.

Authors:  Persephone Borrow; M Anthony Moody
Journal:  Immunol Rev       Date:  2017-01       Impact factor: 12.988

9.  Long-Term Non-Progression and Broad HIV-1-Specific Proliferative T-Cell Responses.

Authors:  Nesrina Imami; Samantha J Westrop; Nathali Grageda; Anna A Herasimtschuk
Journal:  Front Immunol       Date:  2013-03-01       Impact factor: 7.561

10.  Regulatory T cells expanded from HIV-1-infected individuals maintain phenotype, TCR repertoire and suppressive capacity.

Authors:  Mathieu Angin; Paul L Klarenbeek; Melanie King; Siddhartha M Sharma; Eshia S Moodley; Ashley Rezai; Alicja Piechocka-Trocha; Ildiko Toth; Andrew T Chan; Philip J Goulder; Thumbi Ndung'u; Douglas S Kwon; Marylyn M Addo
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.